Literature DB >> 15686497

Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes.

Hong-Hong Yao1, Jian-Hua Ding, Fang Zhou, Fang Wang, Li-Fang Hu, Tao Sun, Gang Hu.   

Abstract

We investigated whether the activation of astroglial group II and III metabotropic glutamate receptors (mGluRs) could exert neuroprotective effects and whether the neuroprotection was related to glutamate uptake. Our results showed that the activation of astroglial group II or III mGluRs exerted neuroprotection against 1-methyl-4-phenylpyridinium (MPP+) astroglial conditioned medium-induced neurotoxicity in midbrain neuron cultures. Furthermore, MPP+ decreased glutamate uptake of primary astrocytes and C6 glioma cells, which was recovered by activating group II or III mGluRs. Specific group II or III mGluRs antagonists completely abolished the neuroprotective effects and the enhancement of glutamate uptake of their respective agonists. Our results showed that the primary cultured rat astrocytes and C6 glioma cells expressed receptor proteins for group II mGluR2/3, group III mGluR4, mGluR6 and mGluR7. C6 glioma cells expressed mRNA for group II mGluR3, group III mGluR4, mGluR6, mGluR7 and mGluR8. In conclusion, we confirmed that the activation of astroglial mGluRs exerted neuroprotection, and demonstrated that the mechanism underlying this protective role was at least partially related to the enhancement of glutamate uptake.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15686497     DOI: 10.1111/j.1471-4159.2004.02937.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  39 in total

1.  Metabotropic glutamate receptor-mediated signaling in neuroglia.

Authors:  David J Loane; Bogdan A Stoica; Alan I Faden
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-11

2.  Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease.

Authors:  Matthew J Betts; Michael J O'Neill; Susan Duty
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

3.  Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3.1.

Authors:  Fuwang Peng; Honghong Yao; Xuetao Bai; Xuhui Zhu; Benjamin C Reiner; Michael Beazely; Keiko Funa; Huangui Xiong; Shilpa Buch
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

4.  Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease.

Authors:  P J Austin; M J Betts; M Broadstock; M J O'Neill; S N Mitchell; S Duty
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

5.  High glutamate decreases S100B secretion by a mechanism dependent on the glutamate transporter.

Authors:  Francine Tramontina; Marina C Leite; Daniela Gonçalves; Ana Carolina Tramontina; Daniela F Souza; Juliana K Frizzo; Patrícia Nardin; Carmem Gottfried; Susana T Wofchuk; Carlos-Alberto Gonçalves
Journal:  Neurochem Res       Date:  2006-06-23       Impact factor: 3.996

Review 6.  Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Faqi Li
Journal:  Curr Neurovasc Res       Date:  2005-12       Impact factor: 1.990

7.  Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity.

Authors:  Honghong Yao; Fuwang Peng; Navneet Dhillon; Shannon Callen; Sirosh Bokhari; Lisa Stehno-Bittel; S Omar Ahmad; John Q Wang; Shilpa Buch
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

8.  Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes.

Authors:  Matthew Neal; Jie Luo; Dilshan S Harischandra; Richard Gordon; Souvarish Sarkar; Huajun Jin; Vellareddy Anantharam; Laurent Désaubry; Anumantha Kanthasamy; Arthi Kanthasamy
Journal:  Glia       Date:  2018-09-12       Impact factor: 7.452

Review 9.  The role of glutamate and the immune system in organophosphate-induced CNS damage.

Authors:  Arik Eisenkraft; Avshalom Falk; Arseny Finkelstein
Journal:  Neurotox Res       Date:  2013-03-27       Impact factor: 3.911

10.  TRPC channel-mediated neuroprotection by PDGF involves Pyk2/ERK/CREB pathway.

Authors:  H Yao; F Peng; Y Fan; X Zhu; G Hu; S J Buch
Journal:  Cell Death Differ       Date:  2009-08-14       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.